RZLT logo

RZLT
Rezolute Inc

1,634
Mkt Cap
$310.06M
Volume
525,732.00
52W High
$11.46
52W Low
$1.07
PE Ratio
-3.98
RZLT Fundamentals
Price
$3.30
Prev Close
$3.22
Open
$3.15
50D MA
$3.15
Beta
0.72
Avg. Volume
1.49M
EPS (Annual)
-$0.9791
P/B
2.65
Rev/Employee
$0.00
$172.71
Loading...
Loading...
News
all
press releases
Rezolute (RZLT) to Release Quarterly Earnings on Tuesday
Rezolute (NASDAQ:RZLT) will be releasing its Q3 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at...
MarketBeat·16d ago
News Placeholder
More News
News Placeholder
Rezolute, Inc. (NASDAQ:RZLT) Short Interest Down 21.2% in March
Rezolute, Inc. (NASDAQ:RZLT - Get Free Report) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totaling 13,353,457 shares, a decline of 21.2...
MarketBeat·1mo ago
News Placeholder
What is HC Wainwright's Estimate for Rezolute Q1 Earnings?
Rezolute, Inc. (NASDAQ:RZLT - Free Report) - HC Wainwright cut their Q1 2027 EPS estimates for Rezolute in a research report issued on Monday, March 30th. HC Wainwright analyst D. Tsao now...
MarketBeat·2mo ago
News Placeholder
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earlier phase III setback in the congenital HI study.
Zacks·2mo ago
News Placeholder
Rezolute (NASDAQ:RZLT) Stock Rating Upgraded by Wedbush
Wedbush upgraded Rezolute from a "neutral" rating to an "outperform" rating and upped their price objective for the stock from $2.00 to $5.00 in a report on Wednesday...
MarketBeat·2mo ago
News Placeholder
FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question
Rezolute shares rise after FDA feedback on sunRIZE trial; mixed efficacy, data review ahead for rare genetic disorder drug.read more...
Benzinga·2mo ago
News Placeholder
Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Rezolute, Inc. (NASDAQ:RZLT - Get Free Report) have earned a consensus rating of "Hold" from the eleven brokerages that are presently covering the firm, MarketBeat.com reports. One equities...
MarketBeat·2mo ago
News Placeholder
22NW LP Invests $7.71 Million in Rezolute, Inc. $RZLT
22NW LP purchased a new position in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange...
MarketBeat·2mo ago
News Placeholder
Mangrove Partners IM LLC Acquires 584,660 Shares of Rezolute, Inc. $RZLT
Mangrove Partners IM LLC increased its holdings in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 25.4% in the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·2mo ago
News Placeholder
RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rezolute, Inc. (Rezolute or the Company) (NASDAQ: RZLT). This press release features...
Business Wire·3mo ago
<
1
2
...
>

Latest RZLT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.